• API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride
  • API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride
  • API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride
  • API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride
  • API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride
  • API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride

API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 250/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application & Function
  • Specification
Overview

Basic Info.

Model NO.
Dsung-Glimepiride
Product Name
Glimepiride
Name
Glimepiride Powder
Appearance
White Fine Powder
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical Intermediate
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
93479-97-1
Mf
C24h34n4o5s
MW
490.61556
Density
1.29
Melting Point
212-214 C
Boiling Point
677.0+-65.0 C at 760 Mmhg
Transport Package
Negotiable
Specification
99%
Trademark
D-Sung
Origin
Shaanxi
Production Capacity
3 Ton/Month

Product Description

API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride
API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride
 
Product Description

API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideAPI CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride

Product Details

API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride

Product Name Glimepiride
CAS No. 93479-97-1
MF C24H34N4O5S
MW 490.61556
Appearance and shape White fine Powder
Glimepiride is a third-generation sulfonylureas long-acting anti-diabetes drug.  The main mechanism of its hypoglycemic effect is to stimulate the secretion of by beta cells of the pancreas and partially increase the sensitivity of surrounding tissues.  This product binds to receptor and dissociates faster than glyburide, and causes less severe hypoglycemia.  Its mechanism is through and sulfonyl urea receptors on the surface of the pancreatic beta cells (relative molecular mass of 6.5 x 104 protein), the receptor and ATP sensitive K + (KATP) channel phase coupling, pushing the KATP channel close, cause cell membrane depolarization, makes the open voltage dependent calcium channel, Ga2 + internal flow and lead to the release, and inhibit the synthesis of liver glucose.  Recent studies have shown that different sulfonylurea coal drugs have different affinities with KATP.  The following order: Glenn beauty urea > tolbutamide > sulfonyl chloride propyl urea.  In addition, it could be a glucose transporter factor 1, 4 caused by two kinds of protein expression is increased.  Due to Glenn beauty of urea to cardiovascular KATP channels in the weaker than Glenn wave urea, gliclazide pass column pyrazine.  So cardiovascular adverse reactions are also rare.
Application & Function

API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideGlimepiride is a medium- to long-acting sulfonylureaantidiabetic drug. Glimepiride (Glimer) is indicated to treat type 2 diabetes mellitus;   its mode of action is to increase in'sulin production by the pancreas.   It is not used for type 1 diabetes because in type 1 diabetes the pancreas is not able to produce in'sulin.  Its use is contraindicated in patients with hypersensitivity to glimepiride or other sulfonylureas, and during pregnancy.

Specification

API CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideAPI CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideAPI CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideAPI CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideAPI CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideAPI CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder GlimepirideAPI CAS 93479-97-1 Glimepiride Pharmaceutical Intermediate Glimepiride Tablet Powder Glimepiride

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP